Some use cannabidiol to cope with chronic pain in the form of a substitute for addictive drugs, like opioids. There is a lack of research to substantiate cannabidiol’s analgesic effects. Anyhow, what we are aware of thus far is promising. Cannabidiol shows promise as an item for easing both discomfort and chronic pain associated with many different conditions.
Some multiple sclerosis symptoms that cannabidiol may aid in treating are fatigue, spasticity, mobility, nerve-related discomfort/pain, itching, and pain. Now, does that mean it is a good idea to use CBD for multiple sclerosis? Perhaps it is, but you should do as much research into it as possible for informed decisions. Keep reading this post if you wish to have help with making those kinds of decisions.
CBD For Pain
A recent review suggests that cannabidiol may be efficacious in managing pain without many negative secondary effects. The pieces of research it looked at include pain emerging from neuropathy, fibromyalgia, and cancer.
CBD For Inflammation
Scientific researchers have looked at cannabidiol’s anti-inflammatory capabilities, as well. An animal study from 2015 suggested that rats with arthritis getting 6.2 milligrams of cannabidiol daily had less pain and swelling as compared to other rats. The results may be interesting, but research involving human beings is required to confirm those findings.
Cannabidiol For MS Symptoms
There are also some studies about CBD and multiple sclerosis that looked at whether the substance might help individuals cope with the symptoms. Anyhow, almost all of those studies examine cannabidiol and THC’s effects together.
A study featured in 2018 looked at cannabidiol’s effects on MS patients’ driving capabilities. It found that there was no increase in vehicular accident count among people who consumed a particular form of CBD. People reported better driving capabilities, too, possibly due to CBD-induced reduced spasticity.
One more 2018 study discovered that cannabis derivatives with equal amounts of cannabidiol and tetrahydrocannabinol in each dosage, may lessen MS patients’ pain and muscle spasticity. Cannabis may reduce the fatigue related to inflammation, as well, which can make those MS patients’ mobility better.
The National MS Society not only bats for cannabis legalization at a state level but also looks to remove US federal obstacles to medical cannabis research. It points out that there exists a lack of research about how safe cannabis use is, especially in multiple sclerosis patients.